These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4338441)

  • 41. Cyclic AMP in the cerebrospinal fluid of patients with recent cerebral infarction.
    Mrsulja BB; Djuricić BM; Kostić VS; Panić M
    Eur Neurol; 1984; 23(3):201-5. PubMed ID: 6088247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depression of cyclic AMP and cyclic GMP in the cerebrospinal fluid of rats after acute administration of ethanol.
    Weitbrecht WU; Cramer H
    Brain Res; 1980 Nov; 200(2):478-80. PubMed ID: 6251948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of probenecid on the free and conjugaed 3-methoxy-4-hydroxyphenylglycol (MHPG) in lumbar cerebrospinal fluid.
    Karoum F; van Kammen DP; Bunney WE; Gillin JC; Jimerson DC; Post RM; Wyatt RJ
    Psychopharmacol Commun; 1976; 2(2):141-8. PubMed ID: 790476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cerebrospinal fluid cAMP and cGMP in various peripheral and central nervous system diseases. Preliminary report].
    Jurkowski A; Czernicki J; Maciejek Z
    Neurol Neurochir Pol; 1981; 15(3):277-82. PubMed ID: 6273761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Concentrations of cyclic nucleotides in the cerebrospinal fluid of the aged patients with dementia (author's transl)].
    Eto F; Okano K; Yoshikawa M; Hirai S
    Rinsho Shinkeigaku; 1979 Jan; 19(1):22-6. PubMed ID: 218760
    [No Abstract]   [Full Text] [Related]  

  • 46. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.
    Rinne UK; Sonninen V
    Neurology; 1972 Jan; 22(1):62-7. PubMed ID: 4550499
    [No Abstract]   [Full Text] [Related]  

  • 47. Alcohol, sleep and cerebrospinal fluid changes in alcoholics: cyclic AMP and biogenic amine metabolites in CSF.
    Zarcone V; Schreier L; Barchas J; Orenberg E; Benson K
    Adv Exp Med Biol; 1977; 85A():593-9. PubMed ID: 200121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in the cerebrospinal fluid levels of adenosine cyclic- 3',5'-monophosphate (c-AMP) in patients with generalized tonic-clonic epileptic seizures].
    Szczechowski L; Wajgt A; Marczewska E
    Neurol Neurochir Pol; 1991; 25(3):332-6. PubMed ID: 1660110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 50. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
    Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
    Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of methotrexate transport from cerebrospinal fluid by probenecid.
    Spector R
    Cancer Treat Rep; 1976 Jul; 60(7):913-6. PubMed ID: 1009521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of probenecid on methotrexate exchange between the blood and the cerebrospinal fluid.
    Domer FR; Kaiser LR
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):17-24. PubMed ID: 849061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of sodium salicylate on the febrile response and increased levels of cyclic AMP in cerebrospinal fluid during endogenous pyrogen-induced fever in rabbits.
    Liu XY; Li CJ
    Sci China B; 1989 Oct; 32(10):1215-23. PubMed ID: 2553052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
    Fujimoto A
    Seishin Shinkeigaku Zasshi; 1980; 82(5):275-91. PubMed ID: 6157171
    [No Abstract]   [Full Text] [Related]  

  • 55. Cyclic AMP and GMP in the cerebrospinal fluid after high-dose haloperidol treatment.
    Belmaker RH; Zohar J; Rimon R; Averbuch I
    Pol J Pharmacol Pharm; 1984; 36(2-3):217-20. PubMed ID: 6089157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A preliminary study of concentration of cyclic AMP in the cerebrospinal fluid of neurosurgical patients (author's transl)].
    Du ZW
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):30-2. PubMed ID: 6284454
    [No Abstract]   [Full Text] [Related]  

  • 57. Probenecid inhibition of methotrexate-cerebrospinal fluid pharmacokinetics in dogs.
    Ramu A; Fusner JE; Blaschke T; Glaubiger DL
    Cancer Treat Rep; 1978 Oct; 62(10):1465-70. PubMed ID: 581360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated levels of cerebrospinal fluid guanosine 3',5'-cyclic monophosphate (C-GMP) in systemic lupus erythematosus.
    Kassan SS; Kagen LJ
    Am J Med; 1978 May; 64(5):732-41. PubMed ID: 206141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of probenecid and large dose amphetamine administration on cerebrospinal fluid homovanillic acid.
    Angrist BM; Wilk S; Gershon S
    Biol Psychiatry; 1974 Feb; 8(1):113-4. PubMed ID: 4815338
    [No Abstract]   [Full Text] [Related]  

  • 60. Cerebrospinal fluid adenosine 3',5'-monophosphate, 5-hydroxyindoleacetic acid and homovanillic acid in patients with sleep apnoea syndrome.
    Cramer H; Warter JM; Renaud B; Krieger J; Marescaux CH; Hammers R
    J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1165-7. PubMed ID: 6174700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.